Genelux Corp (NASDAQ: GNLX) on Monday, plunged -23.52% from the previous trading day, before settling in for the closing price of $4.55. Within the past 52 weeks, GNLX’s price has moved between $1.99 and $8.53.
Annual sales at Healthcare sector company slipped by -14.03% over the past five years. The company achieved an average annual earnings per share of 10.88%. With a float of $33.12 million, this company’s outstanding shares have now reached $37.61 million.
Genelux Corp (GNLX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Genelux Corp is 12.97%, while institutional ownership is 30.67%. The most recent insider transaction that took place on Aug 21 ’25, was worth 10,807. In this transaction SVP, Clinical Development of this company sold 3,219 shares at a rate of $3.36, taking the stock ownership to the 146,817 shares. Before that another transaction happened on Nov 17 ’25, when Company’s SVP, Clinical Development sold 973 for $5.37, making the entire transaction worth $5,224. This insider now owns 145,844 shares in total.
Genelux Corp (GNLX) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.26 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.18) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.61% during the next five years compared to -14.03% drop over the previous five years of trading.
Genelux Corp (NASDAQ: GNLX) Trading Performance Indicators
Genelux Corp (GNLX) is currently performing well based on its current performance indicators. A quick ratio of 4.20 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.88, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.95 in one year’s time.
Technical Analysis of Genelux Corp (GNLX)
Genelux Corp (NASDAQ: GNLX) saw its 5-day average volume 0.18 million, a negative change from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 53.72%.
During the past 100 days, Genelux Corp’s (GNLX) raw stochastic average was set at 8.18%, which indicates a significant increase from 7.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.33 in the past 14 days, which was lower than the 0.44 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.38, while its 200-day Moving Average is $3.86. Nevertheless, the first resistance level for the watch stands at $4.53 in the near term. At $5.58, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.17. If the price goes on to break the first support level at $2.89, it is likely to go to the next support level at $2.30. The third support level lies at $1.25 if the price breaches the second support level.
Genelux Corp (NASDAQ: GNLX) Key Stats
Market capitalization of the company is 132.42 million based on 38,052K outstanding shares. Right now, sales total 10 K and income totals -29,870 K. The company made 0 K in profit during its latest quarter, and -7,950 K in sales during its previous quarter.
